EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents

Karol Jędrejko iD, Oliver Catlin, Timothy Stewart, Ashley Anderson, Bożena Muszyńska, Don H Catlin

Drug Testing and Analysis · 2023-08 · 15 (8) · 803-839

DOI: 10.1002/dta.3529 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Testing and Analysis, online erschienen am 25.06.2023. Verfasst von Karol Jędrejko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutical Botany, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Nootropic Agents, Central Nervous System Stimulants, Doping in Sports. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 198 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first nootropic prohibited in sport was fonturacetam (4‐phenylpiracetam, carphedon) in 1998. Presented here 25 years later is a broad‐scale consideration of the history, pharmacology, prevalence, regulations, and doping potential of nootropics viewed through a lens of 50 selected dietary supplements (DS) marketed as “cognitive enhancement,” “brain health,” “brain boosters,” or “nootropics,” with a focus on unauthorized ingredients. Nootropic DS have risen to prominence over the last decade often as multicomponent formulations of bioactive ingredients presenting compelling pharmacological questions and potential public health concerns. Many popular nootropics are unauthorized food or DS ingredients according to the European Commission including huperzine A, yohimbine, and dimethylaminoethanol; unapproved pharmaceuticals like phenibut or emoxypine (mexidol); previously registered drugs like meclofenoxate or reserpine; EU authorized pharmaceuticals like piracetam or vinpocetine; infamous doping agents like methylhexaneamine or dimethylbutylamine; and other investigational substances and peptides. Several are authorized DS ingredients in the United States resulting in significant global variability as to what qualifies as a legal nootropic. Prohibited stimulants or ß2‐agonists commonly used in “pre‐workout,” “weight loss,” or “thermogenic” DS such as octodrine, hordenine, or higenamine are often stacked with nootropic substances. While stimulants and ß2‐agonists are defined as doping agents by the World Anti‐Doping Agency (WADA), many nootropics are not, although some may qualify as non‐approved substances or related substances under catch‐all language in the WADA Prohibited List. Synergistic combinations, excessive dosing, or recently researched pharmacology may justify listing certain nootropics as doping agents or warrant additional attention in future regulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nootropic AgentsCentral Nervous System StimulantsDoping in SportsPrevalenceDietary SupplementsPharmaceutical Preparations

Stichwörter der Autor:innen

dopingesportsnootropicssupplements contaminationsupplements safety

Substanzen

Nootropic AgentsCentral Nervous System StimulantsPharmaceutical Preparations

Autor:innen und Institutionen

  • Faculty of Pharmacy, Department of Pharmaceutical Botany, Jagiellonian University Medical College, Kraków, Poland.
  • Banned Substances Control Group (BSCG), Los Angeles, California, USA.
  • International Sports Pharmacists Network, Fort Collins, Colorado, USA.
  • Department of Medicine and Molecular and Medical Pharmacology, University of California Los Angeles (UCLA), Los Angeles, California, USA.

ORCID-Profile: Karol Jędrejko

Zitieren

APA

Jędrejko, K., Catlin, O., Stewart, T., Anderson, A., Muszyńska, B., & Catlin, D. H. (2023). Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents. Drug Testing and Analysis, 15(8), 803-839. https://doi.org/10.1002/dta.3529

Vancouver

Jędrejko K, Catlin O, Stewart T, Anderson A, Muszyńska B, Catlin DH. Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents. Drug Testing and Analysis. 2023;15(8):803-839. doi:10.1002/dta.3529

BibTeX
@article{Jdrejko2023,
  author = {Jędrejko, Karol and Catlin, Oliver and Stewart, Timothy and Anderson, Ashley and Muszyńska, Bożena and Catlin, Don H},
  title = {Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents},
  journal = {Drug Testing and Analysis},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {803--839},
  doi = {10.1002/dta.3529}
}
Kostenlos starten →